Human cancer related EMT is characterized with upregulation of the enzymes that decompose the extracellular matrix (such as MMPs) and mesenchymal markers (including Vimentin, Catenin beta and N-cadherin), and downregulation of epithelial markers (including E-cadherin and Cytokeratin7) [51]. The gene discussed is CDH1; the disease is cancer.